医疗器械的益处风险分析方法:系统性审查
Oscar Freyer1, Fatemeh Jahed1, Max Ostermann1
1Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany.
Expert review of medical devices
|June 10, 2025
概括
医疗器械 (MD) 的利益风险分析 (BRA) 通常涉及主观决策,即使使用定量方法. 目前的BRA方法可能不足以有效指导开发人员和监管机构.
科学领域:
- 医疗器械监管法规 医疗器械监管法规
- 卫生技术评估 卫生技术评估
- 风险管理 风险管理
背景情况:
- 医疗器械 (MDs) 既有好处又有风险.
- 监管框架要求进行利益风险分析 (BRA) 来权衡这些因素.
- 现有的BRA方法需要评估是否足够.
研究的目的:
- 确定目前BRA对MDs的方法.
- 评估这些BRA方法的优点和弱点.
- 评估它们在指导开发者和监管机构方面的充分性.
主要方法:
- 在五个数据库中进行了PRISMA-S文献搜索.
- 包括同行评审的出版物,描述了MDs的BRA方法.
- 不包括不相关的技术,制药,非英语和不充分的描述.
主要成果:
- 从包括的17项研究中确定了16种不同的BRA方法.
- 方法在客观性和使用数值计算方面显示出显著的差异.
- 在客观性和数字计算使用之间观察到强烈的相关性.
结论:
- 定量BRA方法仍然涉及对终点的识别和相关性的主观决定.
- 目前的BRA方法可能无法消除主观性和偏见.
- 现有的BRA方法往往是有限的,可能不足以提供监管指导.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Hazard Ratio
263
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
263
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K


